An updated view on the influence of initial opioid prescription characteristics on long-term opioid use among opioid naïve patients

This retrospective cohort study provides an updated view on the association between the likelihood of long-term opioid use (LTOU) and characteristics of the initial opioid prescription (dose, opioid type) and initial opioid prescription episode (days’ supplied) among opioid-naïve patients utilizing...

Full description

Saved in:
Bibliographic Details
Published inDrug and alcohol dependence Vol. 265; p. 112463
Main Authors Smith, Allen M., Shah, Anuj, Martin, Bradley C.
Format Journal Article
LanguageEnglish
Published Ireland Elsevier B.V 01.12.2024
Subjects
Online AccessGet full text
ISSN0376-8716
1879-0046
1879-0046
DOI10.1016/j.drugalcdep.2024.112463

Cover

More Information
Summary:This retrospective cohort study provides an updated view on the association between the likelihood of long-term opioid use (LTOU) and characteristics of the initial opioid prescription (dose, opioid type) and initial opioid prescription episode (days’ supplied) among opioid-naïve patients utilizing IQVIA PharMetrics®Plus for Academics database representative of commercially insured patients in the US. Kaplan-Meier estimates were used to determine opioid continuation likelihood at 365 days stratified by the characteristics of the initial opioid prescription and initial opioid prescription episode. Cox-proportional hazard models were estimated to determine the strength of association between initial opioid prescription characteristics and opioid continuation. A total of 578,403 cancer-free, SUD-free, opioid-naïve subjects aged ≥14 years that filled ≥1 opioid prescriptions between April 13, 2016 and April 18, 2020 were identified and categorized based on time to opioid discontinuation. After accounting for censoring, 5.05 % of persons continued opioid use for ≥365 days. Compared to a 1–2 days’ supply (DS), the likelihood of opioid discontinuation was consistently lower with higher DS [HRs (CIs): 3–4 days' supply = 0.66 (0.65–0.66); 5–7 DS = 0.41 (0.41–0.41); 8–10 DS = 0.33 (0.33–0.34); 11–14 DS = 0.30 (0.29–0.31); 15–21 DS = 0.26 (0.26–0.27); ≥22 DS = 0.17 (0.17–0.18)]. These associations between increased DS and decreased likelihood of discontinuing opioid remained consistent across different pain etiologies. In this era of more conservative opioid prescribing, increases in DS remains the strongest factor associated with a higher likelihood of LTOU. •Fewer persons are transitioning to long-term opioid use compared to the previous decade.•Among persons initiating opioids, 5.05 % of them continued opioid use for ≥365 days.•The days’ supplied of the initial opioid prescription remained the strongest factor associated with long-term opioid use.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0376-8716
1879-0046
1879-0046
DOI:10.1016/j.drugalcdep.2024.112463